Literature DB >> 3354257

Influenza virus ISCOMs: biochemical characterization.

B Sundquist1, K Lövgren, S Höglund, B Morein.   

Abstract

Immunostimulating complexes (ISCOMs) have been prepared from influenza A virus envelope glycoproteins, i.e. haemagglutinin (HA) and neuraminidase (NA). An ISCOM consists of a matrix, which is the micellar form of the glycoside, Quil A, in hydrophobic interaction with both the envelope glycoproteins (HA/NA). The Quil A bound to the ISCOM amounted to 50 micrograms mg-1 (5%) of ISCOM protein. ISCOMs were morphologically identified as symmetrical cage-like structures of approximately equal to 40 nm in diameter with hexagonal or pentagonal subunits of approximately equal to 12 nm. The sedimentation coefficient was approximately equal to 19 S as compared to 30 S for the glycoprotein micelles. The biological activities of the HA and NA are preserved in both ISCOMs and micelles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354257     DOI: 10.1016/0264-410x(88)90013-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.

Authors:  A J Winter; G E Rowe; J R Duncan; M J Eis; J Widom; B Ganem; B Morein
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

2.  The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.

Authors:  K F Hu; M Elvander; M Merza; L Akerblom; A Brandenburg; B Morein
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.

Authors:  M Villacres-Eriksson; M Bergström-Mollaoglu; H Kåberg; K Lövgren; B Morein
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

Review 4.  Respiratory viral infections in the elderly.

Authors:  J Treanor; A Falsey
Journal:  Antiviral Res       Date:  1999-12-15       Impact factor: 5.970

Review 5.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.